Metraipolis › archive › dc_0db8cf013c8b
From bench to bedside: investigating SGLT2 inhibitors as a novel strategy against chemotherapy-induced cardiomyopathy — Europe PMC PMID:41059442
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41059442
- DOI
- 10.3389/fcvm.2025.1647747
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T20:06:00.781Z
- SHA-256 of the archived text
bd0fdb7054fe0a1c9bdbcbf7689a41bb7969362a6bbc1d1d7dd4227b88e350ab- Stable URL of this page
https://metraipolis.com/documento/dc_0db8cf013c8b
How to cite
From bench to bedside: investigating SGLT2 inhibitors as a novel strategy against chemotherapy-induced cardiomyopathy — Europe PMC PMID:41059442 — Europe PMC (en), https://europepmc.org/article/MED/41059442 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0db8cf013c8b (Metraipolis archive dc_0db8cf013c8b, sha256 bd0fdb7054fe0a1c9bdbcbf7689a41bb7969362a6bbc1d1d7dd4227b88e350ab)
BibTeX
@misc{dc0db8cf013c8b,
title = {From bench to bedside: investigating SGLT2 inhibitors as a novel strategy against chemotherapy-induced cardiomyopathy — Europe PMC PMID:41059442},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41059442},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0db8cf013c8b; sha256 bd0fdb7054fe0a1c9bdbcbf7689a41bb7969362a6bbc1d1d7dd4227b88e350ab},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41059442. Agents can read the archived copy with the MCP tool read_document.